Spine BioPharma

Spine BioPharma is focused on developing non-surgical therapies aimed at alleviating back pain and restoring functionality without relying on opioids. The company’s lead therapeutic candidate targets degenerative disc disease, offering potential benefits such as pain relief, functional restoration, and the slowing or prevention of disease progression. With a mission to enhance the quality of life for individuals suffering from degenerative spine conditions, Spine BioPharma seeks to deliver clinically proven, safe, and effective treatments that address pain and inflammation. Through its innovative pipeline, the company aims to improve the everyday lives of millions affected by these debilitating conditions.